CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 30,000 target
Drug / intervention
Non-Interventional Studyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06271291
NCT06271291N/ARecruitingOn Track
CompareCT.gov

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

Mayo Clinic·observational·Posted Feb 21, 2024·Updated Jun 1, 2026

In Brief

An observational study evaluating Non-Interventional Study for Pancreatic Carcinoma. Currently recruiting, targeting 30,000 participants across 9 sites.

Detailed Summary

This study evaluates individuals without pancreatic cancer, but who have been determined to be at higher-than-average lifetime risk of developing pancreatic cancer to help detect pancreatic cancer or other cancers at an earlier time when they might be more easily treated and cured.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Carcinoma
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ARecruiting
202420252026202720282029
First PostedFeb 21, 2024
Enrollment StartDec 12, 2024
Primary CompletionNov 1, 2029
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 2.4 years agoPrimary completion in 3.3 years

Arms & Interventions

Observationalother

Participants undergo blood sample collection, complete questionnaires, have their medical records reviewed and undergo pancreatic cyst fluid collection during standard of care endoscopic ultrasounds fine needle aspiration.

Other: Non-Interventional Study

Interventions

Non-Interventional Studyother

Non-interventional study